Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Baxter
Fish and Richardson
Farmers Insurance
Julphar

Generated: July 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BIMATOPROST

Try a free trialSee Plans and Pricing

« Back to Dashboard

Clinical Trials for BIMATOPROST

Trial ID Title Status Sponsor Phase Summary
NCT00187577 Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata Completed University of California, San Francisco N/A This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day.
NCT00273455 Lumigan Versus Cosopt Completed Pharmaceutical Research Network Phase 4 To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy
NCT00300443 Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension Completed Allergan Phase 2/Phase 3 The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
NCT00332059 Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension Completed Allergan Phase 3 The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
NCT00332072 Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension Completed Allergan Phase 3 The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in the treatment of glaucoma or ocular hypertension
NCT00332540 Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension Completed Allergan Phase 3 The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for BIMATOPROST

Condition Name

Condition Name for BIMATOPROST
Intervention Trials
Ocular Hypertension 66
Glaucoma 39
Glaucoma, Open-Angle 19
Open-Angle Glaucoma 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for BIMATOPROST
Intervention Trials
Ocular Hypertension 69
Glaucoma 63
Hypertension 55
Glaucoma, Open-Angle 40
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for BIMATOPROST

Trials by Country

Trials by Country for BIMATOPROST
Location Trials
United States 203
Canada 20
Germany 19
Italy 18
United Kingdom 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for BIMATOPROST
Location Trials
California 33
Texas 14
Pennsylvania 13
Florida 9
North Carolina 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for BIMATOPROST

Clinical Trial Phase

Clinical Trial Phase for BIMATOPROST
Clinical Trial Phase Trials
Phase 4 48
Phase 3 25
Phase 2/Phase 3 1
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for BIMATOPROST
Clinical Trial Phase Trials
Completed 92
Recruiting 15
Unknown status 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for BIMATOPROST

Sponsor Name

Sponsor Name for BIMATOPROST
Sponsor Trials
Allergan 74
Alcon Research 7
ForSight Vision5, Inc. 5
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for BIMATOPROST
Sponsor Trials
Industry 95
Other 34
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
Accenture
Moodys
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.